Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Hematologic Oncology Update
00:00
Mosunetuzumab in Older/Fixed‑Duration FL
Matt explains mosunetuzumab as a tolerable fixed‑duration option for elderly FL patients and infection risks with prolonged bispecifics.
Play episode from 10:48
Transcript
